AI English summary of an SEC filing — figures as filed
CVS Health CVSCVS Health recorded an operating loss of $3.2 billion for the quarter ended September 30, 2025, compared to operating income of $832 million in the prior year. The company said a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit was the primary driver of the difference.
Key points
AI summaryCVS Health recorded an operating loss of $3.2 billion for the quarter ended September 30, 2025, compared to operating income of $832 million in the prior year. The company said a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit was the primary driver of the difference.
CVS Health cited $1.2 billion in legacy litigation charges related to two court decisions, a $320 million opioid litigation charge and $288 million in pre-tax losses on Accountable Care assets as factors in the $2.3 billion increase in operating expenses for the 9 months ended 2025.
The company said medical membership in its Health Care Benefits segment for Q3 2025 declined to 92.8% from 95.2% in the prior year, while adjusted operating income was $314 million compared to an adjusted operating loss of $924 million in the prior year.
CVS Health said that as of September 30, 2025, it had approximately $9.1 billion in cash and cash equivalents and $1.2 billion in commercial paper outstanding, with no borrowings outstanding under its back-up credit facilities.
Key figures
Quarter ended September 30, 2025
- Revenue
- $102.9B
- Operating income
- −$3.2B
- Net income
- −$4.0B
- EPS
- −$3.13
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Quarterly operating loss and operating income change
CVS Health recorded an operating loss of $3.2 billion for the quarter ended September 30, 2025, compared to operating income of $832 million in the prior year. The company said a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit was the primary driver of the difference.
Source · Based on the MD&A text of the filing
Explanation of 9-month operating expense increase
CVS Health cited $1.2 billion in legacy litigation charges related to two court decisions, a $320 million opioid litigation charge and $288 million in pre-tax losses on Accountable Care assets as factors in the $2.3 billion increase in operating expenses for the 9 months ended 2025.
Source · Based on the MD&A text of the filing
Health Care Benefits quarterly medical membership and adjusted operating income
The company said medical membership in its Health Care Benefits segment for Q3 2025 declined to 92.8% from 95.2% in the prior year, while adjusted operating income was $314 million compared to an adjusted operating loss of $924 million in the prior year.
Source · Based on the MD&A text of the filing
Liquidity: cash and short-term borrowing position
CVS Health said that as of September 30, 2025, it had approximately $9.1 billion in cash and cash equivalents and $1.2 billion in commercial paper outstanding, with no borrowings outstanding under its back-up credit facilities.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…